Myriad Genetics Inc.

Gregory Critchfield, M.D., President of Myriad Genetic Laboratories, Inc., a wholly owned subsidiary, joined the Company in July 1998. Dr. Critchfield previously served as Senior Vice President, Chief Medical and Scientific Officer of Quest Diagnostics (formerly Corning Clinical Laboratories). Dr. Critchfield received his M.D. from the University of Utah and his M.S. in Biophysical Sciences from the University of Minnesota. He is Board Certified in Clinical Pathology.

James S. Evans, Chief Financial Officer, joined Myriad in 1995. Mr. Evans served as Myriad's Corporate Controller from 1995 until July 2005 when he was named Vice President, Finance, a position he held until November 2007 when he was named Chief Financial Officer. Mr. Evans began his career in the Audit/Attestation division of the international accounting firm of KPMG, LLP where he held several positions. He worked as the Controller for Genmark, Inc. and Shaperite Concepts, Ltd. prior to joining Myriad. Mr. Evans received a Bachelor of Science and Master of Accounting degrees from Brigham Young University in 1987 and is a Certified Public Accountant licensed in the State of Utah.

Mark C. Capone, Chief Operating Officer of Myriad Genetics Laboratories, joined the company in October 2002. He was previously Senior Vice President of Sales. Prior to joining Myriad, Mr. Capone served 17 years with Eli Lilly and Company where he held positions as Product Development Manager, Manufacturing Plant Manager, and Area Sales Director. Mr. Capone received his Bachelor of Science degree in Chemical Engineering from Penn State University graduating with highest distinction, his Master of Science degree in Chemical Engineering from Massachusetts Institute of Technology, and his Master of Science in Management from Massachusetts Institute of Technology.

Robert G. Harrison, Chief Information Officer, joined Myriad in 1996. Mr. Harrison served as Myriad's Network Administrator from 1996 to 2000. He was then named Director of Information Systems and Technology from 2000 until January 2005. He was then named Vice President of Information Systems and Technology, a position he held until January 2008 when he was named Chief Information Officer. Mr. Harrison began his career in IT working for several private companies and consulting firms where he held several positions in technical support, sales and management capacities. Mr. Harrison received a Bachelor of Science degree in Business Administration with a minor in Computer Science from the University of Utah in 1994.

Jerry Lanchbury, Ph.D., Executive Vice President of Research and Development joined Myriad in September 2002. Dr. Lanchbury graduated from the University of Aston, Birmingham, UK. He earned his doctorate in population genetics from the University of Newcastle upon Tyne and subsequently completed his postdoctoral fellowship at the United Medical & Dental Schools of the University of London in Human Disease Genetics. Dr. Lanchbury is a highly respected expert in immunogenetics with more than 100 reviewed research journal publications.

Richard Marsh, Executive Vice President, General Counsel and Secretary joined Myriad in November 2002. Prior to joining Myriad, Mr. Marsh served in various positions at Iomega Corporation including Acting General Counsel, Director of IP and Director of Commercial Legal Affairs. Richard received a Masters of Laws degree in Taxation from Georgetown University Law Center; a law degree from Thomas M. Cooley Law School, graduating magna cum laude; and a Bachelor of Science degree in Accounting from Brigham Young University; and was formerly a Certified Public Accountant.

Linda Wilson, Lead Teacher, Fifth Grade, is in her ninth year of teaching and her second at CLCS. She has degrees from the University of Wisconsin and Cardinal Stritch College. Before coming to CLCS, Ms. Wilson integrated music with instruction and is happy to now be teaching at a school with a Learning through Music model. Ms. Wilson plays clarinet and is learning to play violin.

Robert S. Attiyeh, Member of the Board of Directors, was elected to the board in 2003. He currently serves as Chairman of the Board's audit committee. Mr. Attiyeh is a principal in the real estate investment firms of Beacon Hill Properties LLC and Yarlung LLC. He previously served Amgen from 1994 - 1998 as Senior Vice President, Finance and Corporate Development and as Chief Financial Officer. Prior to joining Amgen, Mr. Attiyeh was a director of McKinsey and Company from 1967 - 1994. He was a Director of the Federal Reserve Bank of San Francisco from 1987 - 1992 and served as Chairman of the Audit Review Committee of the Bank's Board from 1988 - 1992. He is currently on the Board of Directors of Source Precision Medicine of Boulder, Colorado, where he is Chairman of the Board's Audit Committee. Mr. Attiyeh holds a masters in business administration from Harvard and an electrical engineering degree from Cornell. Mr. Attiyeh is a member of Class Three of the Board, with a term expiring at our 2009 annual meeting.